Menu Search
Equities

EMV Capital PLC

  • Add to watchlist
  • Add to portfolio
  • Add an alert
NTK1:STU

EMV Capital PLC

Actions
  • Price (EUR)0.575
  • Today's Change0.005 / 0.88%
  • Shares traded0.00
  • 1 Year change+6.48%
  • Beta1.4353
Data delayed at least 15 minutes, as of Feb 11 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

EMV Capital plc is a United Kingdom-based deep tech and life sciences venture capital (VC) investment group with an international portfolio of companies. The Company identifies, invests in, and builds high-growth companies in the United Kingdom and internationally. It employs a capital-light investment approach, making use of its balance sheet and syndicating investments through its wholly owned VC subsidiary, EMV Capital Partners Limited. It secures a mixture of direct equity stakes and carried interest stakes in its portfolio of companies, creating a structure that can support a large portfolio. The Company has a portfolio of approximately 70 companies with a focus on life sciences, industrials, robotics & artificial intelligence (AI), and sustainability. Its subsidiaries include Glycotest, Inc., CetroMed Limited, NetScientific America, Inc., EMV Director Services Limited, EMV Capital Technology Limited, and ProAxsis Limited, among others.

  • Revenue in GBP (TTM)2.36m
  • Net income in GBP-2.50m
  • Incorporated2012
  • Employees24.00
  • Location
    EMV Capital PLC2nd Floor, 25-28 Old Burlington StreetLONDON W1S 3ANUnited KingdomGBR
  • Phone+44 203 011 2234
  • Websitehttps://emvcapital.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.